The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results from molecular analysis for therapy choice (MATCH) arm I: Taselisib for PIK3CA-mutated tumors.
 
Ian E. Krop
Employment - AMAG Pharmaceuticals (I)
Leadership - AMAG Pharmaceuticals (I)
Stock and Other Ownership Interests - AMAG Pharmaceuticals (I)
Honoraria - Genentech/Roche
Consulting or Advisory Role - Daiichi Sankyo; Genentech/Roche; Seagen
Research Funding - Genentech
 
Opeyemi Jegede
No Relationships to Disclose
 
Juneko E. Grilley-Olson
Research Funding - Genentech (Inst); MedImmune (Inst); NanoCarrier (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst)
 
Josh David Lauring
Employment - Janssen Research & Development
Speakers' Bureau - Abbvie (I); Galderma (I)
Patents, Royalties, Other Intellectual Property - I intermittently receive royalty payments for cell lines created in my laboratory which are licensed for commercial sale to Horizon Discovery, Ltd by Johns Hopkins University.
Travel, Accommodations, Expenses - Abbvie (I); Galderma (I)
 
Stanley R. Hamilton
Consulting or Advisory Role - Bristol-Myers Squibb; HalioDx; Loxo; Merck; Philips Electronics; Thermo Fisher Scientific
 
James A. Zwiebel
No Relationships to Disclose
 
Shuli Li
No Relationships to Disclose
 
Lawrence Rubinstein
No Relationships to Disclose
 
Austin Doyle
No Relationships to Disclose
 
David R. Patton
No Relationships to Disclose
 
Edith P. Mitchell
Honoraria - Sanofi
Consulting or Advisory Role - Genentech
Research Funding - Genentech (Inst); sanofi (Inst)
 
Carlos L. Arteaga
Leadership - American Association for Cancer Research
Stock and Other Ownership Interests - Provista Diagnostics
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; KIYATEC; Lilly; Monogram Biosciences; Novartis; Roche; Seragon; Susan G. Komen for the Cure
Research Funding - AstraZeneca; Novartis; Puma Biotechnology; U3Pharma
 
Barbara A. Conley
No Relationships to Disclose
 
David Sims
No Relationships to Disclose
 
Lyndsay Harris
Patents, Royalties, Other Intellectual Property - Philips Healthcare
 
Alice P. Chen
No Relationships to Disclose
 
Keith Flaherty
Stock and Other Ownership Interests - Clovis Oncology; Loxo; Strata Oncology; X4 Pharma
Consulting or Advisory Role - Adaptimmune; Aeglea Biotherapeutics; Amgen; Asana Biosciences; Bristol-Myers Squibb; Genentech; Incyte; Lilly; Loxo; Merck; Novartis; Oncoceutics; Roche; Sanofi; Shattuck Labs; Tolero Pharmaceuticals
Research Funding - Novartis; Sanofi